In this interview Ellis Martin speaks with Kurt May, Senior Vice-President of International Stem Cell Corporation (ISCO.OB). Mr. May discusses his role with the company and their unique development of the parthenogenic stem cell derived from unfertilized embryonic eggs. He oversees the growth of the company's LIfeline Stem Cell and Lifeline Skin Care revenue generating divisions. The question of immune rejection is overcome with their proprietary technology.
Listen to learn more. http:://www.intlstemcell.com http::/www.ellismartinrepot.com
International Stem Cell Corp is a paid sponsor of The Ellis Martin Report